Conrad C. Bleul

9.9k citations

39 papers · 8.0k indexed · 4 hit papers · h-index 26

Impact in

Virology top 0.2%
- HIV Research and Treatment
Immunology top 0.2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation

Papers in

Immunology 24
- T-cell and B-cell Immunology 16
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 9
Hematology 8
- Hematopoietic Stem Cell Transplantation 7
- Acute Myeloid Leukemia Research 3

Co-authors: Timothy A. Springer Alessandro Aiuti Thomas Boehm Robert C. Fuhlbrigge José M. Casasnovas Hyeryun Choe Michael Farzan Cristina Parolin
Journals: The Journal of Experimental Medicine (6 papers)The Journal of Immunology (5 papers)European Journal of Immunology (4 papers)Proceedings of the National Academy of Sciences (3 papers)Blood (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Conrad C. Bleul

39 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood 1997 · 1.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1997 The Journal of Experimental Medicine
1997 Proceedings of the National Academy of Sciences
1996 The Journal of Experimental Medicine
1996 Nature

Peers

Countries citing papers authored by Conrad C. Bleul

Since Specialization

Citations

This map shows the geographic impact of Conrad C. Bleul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad C. Bleul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad C. Bleul more than expected).

Fields of papers citing papers by Conrad C. Bleul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conrad C. Bleul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad C. Bleul. The network helps show where Conrad C. Bleul may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Conrad C. Bleul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Conrad C. Bleul Line = papers co-authored together Conrad C. Bleul links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches Frontiers in Pharmacology ·Benjamin Ribba, Andreas Roller, Hans‐Joachim Helms, Martin Stern, Conrad C. Bleul	2023	5
2	MORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types Annals of Oncology ·Ian Chau, Georg Martin Haag, Osama E. Rahma, Teresa Macarulla, Steve McCune, Denise A. Yardley, Benjamin Solomon, Melissa L. Johnson, Gregory A. Vidal, Peter Schmid, Guillem Argilés, K. Dimick, Sami Mahrus, Noor Hisham Abdullah, K. Sravani, Pakeeza Sayyed, Hila Barak, Conrad C. Bleul, Edward Cha, Alexandra Drakaki	2018	14
3	Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft Cell stem cell ·John E. Wagner, Claudio G. Brunstein, Anthony E. Boitano, Todd E. DeFor, David H. McKenna, Darin Sumstad, Bruce R. Blazar, Jakub Tolar, Chap T. Le, Julie Jones, Michael P. Cooke, Conrad C. Bleul	2015	237
4	Conversion of the Thymus into a Bipotent Lymphoid Organ by Replacement of Foxn1 with Its Paralog, Foxn4 Cell Reports ·Jeremy B. Swann, 라추선, Daisuke Nagakubo, Conrad C. Bleul, Atsushi Toyoda, Christiane Happe, Nikolai Netuschil, Isabell Hess, Annette Haas‐Assenbaum, Yoshihito Taniguchi, Michael Schorpp, Thomas Boehm	2014	28
5	Maintenance of Thymic Epithelial Phenotype Requires Extrinsic Signals in Mouse and Zebrafish The Journal of Immunology ·Cristian Soza‐Ried, Conrad C. Bleul, Michael Schorpp, Thomas Boehm	2008	48
6	Ltβr Signaling Does Not Regulate Aire-Dependent Transcripts in Medullary Thymic Epithelial Cells The Journal of Immunology ·Vera C. Martins, Thomas Boehm, Conrad C. Bleul	2008	44
7	The stream of precursors that colonizes the thymus proceeds selectively through the early T lineage precursor stage of T cell development The Journal of Experimental Medicine ·Claudia Benz, Vera C. Martins, Freddy Radtke, Conrad C. Bleul	2008	105
8	Bone Marrow-Derived Hemopoietic Precursors Commit to the T Cell Lineage Only after Arrival in the Thymic Microenvironment The Journal of Immunology ·NabilA El-Moghazy, Claudia Benz, Vera C. Martins, Ian D. Haidl, Conrad C. Bleul	2007	72
9	The evolutionary history of lymphoid organs Nature Immunology ·Thomas Boehm, Conrad C. Bleul	2007	94
10	The Foxn1‐dependent transcripts PCOLCE2 and mPPP1R16B are not required for normal thymopoiesis European Journal of Immunology ·NabilA El-Moghazy, Conrad C. Bleul	2007	14
11	Evidence for a Functional Second Thymus in Mice Science ·Grzegorz Terszowski, Susanna Müller, Conrad C. Bleul, Carmen Blum, Reinhold Schirmbeck, Jörg Reimann, Louis Du Pasquier, Takashi Amagai, Thomas Boehm, Hans-Reimer Rodewald	2006	108
12	BMP Signaling Is Required for Normal Thymus Development The Journal of Immunology ·Conrad C. Bleul, Thomas Boehm	2005	140
13	Homing of immature thymocytes to the subcapsular microenvironment within the thymus is not an absolute requirement for T cell development European Journal of Immunology ·Claudia Benz, NabilA El-Moghazy, Conrad C. Bleul	2004	92
14	Genetic dissection of thymus development in mouse and zebrafish Immunological Reviews ·Thomas Boehm, Conrad C. Bleul, Michael Schorpp	2003	62
15	Laser capture microdissection-based expression profiling identifies PD1-ligand as a target of the nude locus gene product European Journal of Immunology ·Conrad C. Bleul, Thomas Boehm	2001	33
16	Chemokines define distinct microenvironments in the developing thymus European Journal of Immunology ·Conrad C. Bleul, Thomas Boehm	2000	173
17	Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes The Journal of Immunology ·Shinsuke Tanabe, M. Heesen, Izumi Yoshizawa, Michael A. Berman, Yi Luo, Conrad C. Bleul, Timothy A. Springer, Keiko Okuda, Norma P. Gerard, Martin E. Dorf	1997	158
18	A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) The Journal of Experimental Medicine ·Conrad C. Bleul, Robert C. Fuhlbrigge, José M. Casasnovas, Alessandro Aiuti, Timothy A. Springer Hit paper breakdown →	1996	1280
19	The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry Nature ·Conrad C. Bleul, Michael Farzan, Hyeryun Choe, Cristina Parolin, Ian Clark‐Lewis, Joseph Sodroski, Zeying Feng Hit paper breakdown →	1996	1683
20	Sequence variation in the E7 gene of human papillomavirus type 18 in tumor and non‐tumor patients and antibody response to a conserved seroreactive epitope International Journal of Cancer ·Jan ter Meulen, Keila Rocio Delgado-Carrasco, Hans Eberhardt, J. Luande, H N Mgaya, Martin Müller, Conrad C. Bleul, Andrejs Bērzinš, Hans Ikenberg, Michael Pawlita, Lutz Gissmann	1993	5

About Conrad C. Bleul

Conrad C. Bleul is a scholar working on Immunology, Hematology, Virology, Oncology and Genetics, having authored 39 papers that have together received 8.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (10 papers), Chemokine receptors and signaling (9 papers), Immunotherapy and Immune Responses (9 papers), Hematopoietic Stem Cell Transplantation (7 papers), Mesenchymal stem cell research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Virology (1.6k citations), Immunology (5.0k citations), Oncology (3.5k citations), Immunology and Allergy (655 citations) and Hematology (1.0k citations). Conrad C. Bleul has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Timothy A. Springer, Alessandro Aiuti, Thomas Boehm, Robert C. Fuhlbrigge, José M. Casasnovas, Hyeryun Choe, Michael Farzan, Cristina Parolin, Ian Clark‐Lewis and Joseph Sodroski. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology, European Journal of Immunology, Proceedings of the National Academy of Sciences and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact